Skip to main content

Advertisement

SpringerLink
Log in

Chronic kidney disease in the shadow of COVID-19: insights from the bibliometric analysis

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

This study aims to present the current status and frontiers of research on COVID-19 in relation to chronic kidney disease through bibliometric analysis and visualization.

Methods

Access to information through the Web of Science Core Collection, retrieved from December 2019 to May 2023. The bibliometric visualization of countries, institutions, and keywords was analyzed using VOSviewer.

Results

A total of 1038 publications are included. The global scientific community showed a high level of collaborative consensus. The three countries with the most publications are the USA, China, and the UK. The institution with the most publications is Harvard Medical School. The research frontier for 2020 is thrombosis, for 2021 is telemedicine, for 2022 is depression, and for 2019–2023 is the COVID-19 vaccines.

Conclusions

This is the first bibliometric report to establish a link between COVID-19 and CKD. The USA, China, and some European countries and their institutions are major contributors to these publications. Thrombosis, telemedicine, depression, and COVID-19 vaccines are current hot topics in the field and have the potential to shape future research trends.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Data availability

All original contributions are included in the manuscript.

References

  1. Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382(8):727–733. https://doi.org/10.1056/NEJMoa2001017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Francis AI, Ghany S, Gilkes T, Umakanthan S (2022) Review of COVID-19 vaccine subtypes, efficacy and geographical distributions. Postgrad Med J 98(1159):389–394. https://doi.org/10.1136/postgradmedj-2021-140654

    Article  PubMed  Google Scholar 

  3. World Health Organization.WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Accessed 30 May 2022

  4. Li Q, Guan X, Wu P et al (2020) Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N Engl J Med 382(13):1199–1207. https://doi.org/10.1056/NEJMoa2001316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. George JA, Khoza S (2021) SARS-CoV-2 infection and the kidneys: an evolving picture. Adv Exp Med Biol 1327:107–118. https://doi.org/10.1007/978-3-030-71697-4_8

    Article  CAS  PubMed  Google Scholar 

  6. Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46(4):586–590. https://doi.org/10.1007/s00134-020-05985-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14(2):185–192. https://doi.org/10.1007/s11684-020-0754-0

    Article  PubMed  PubMed Central  Google Scholar 

  9. Pei G, Zhang Z, Peng J et al (2020) renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol 31(6):1157–1165. https://doi.org/10.1681/ASN.2020030276

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ferreira AJ, Castro CH, Guatimosim S et al (2010) Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1–7)-producing fusion protein in the heart. Ther Adv Cardiovasc Dis 4(2):83–96. https://doi.org/10.1177/1753944709353426

    Article  CAS  PubMed  Google Scholar 

  11. Simõese Silva AC, Silveira KD, Ferreira AJ, Teixeira MM (2013) ACE2, 2013angiotensin-1–7 and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 169(3):477–492. https://doi.org/10.1111/bph.12159

    Article  CAS  Google Scholar 

  12. Crackower MA, Sarao R, Oudit GY et al (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417(6891):822–828. https://doi.org/10.1038/nature00786

    Article  CAS  PubMed  Google Scholar 

  13. Hamming I, Cooper ME, Haagmans BL et al (2007) The emerging role of ACE2 in physiology and disease. J Pathol 212(1):1–11. https://doi.org/10.1002/path.2162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Arentz M, Yim E, Klaff L et al (2020) Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA 323(16):1612–1614. https://doi.org/10.1001/jama.2020.4326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 323(13):1239–1242. https://doi.org/10.1001/jama.2020.2648

    Article  CAS  PubMed  Google Scholar 

  17. Bruchfeld A (2021) The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol 17(2):81–82. https://doi.org/10.1038/s41581-020-00381-4

    Article  CAS  PubMed  Google Scholar 

  18. Betjes MG (2013) Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 9(5):255–265. https://doi.org/10.1038/nrneph.2013.44

    Article  CAS  PubMed  Google Scholar 

  19. Henry BM, Lippi G (2020) Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol 52(6):1193–1194. https://doi.org/10.1007/s11255-020-02451-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. D’Marco L, Puchades MJ, Romero-Parra M et al (2020) Coronavirus disease 2019 in chronic kidney disease. Clin Kidney J 13(3):297–306. https://doi.org/10.1093/ckj/sfaa104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Portolés J, Marques M, López-Sánchez P et al (2020) Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak. Nephrol Dial Transplant 35(8):1353–1361. https://doi.org/10.1093/ndt/gfaa189

    Article  CAS  PubMed  Google Scholar 

  22. Wang J, Wang X, Cai X, Pan D (2023) Global trends and hotspots in IgA nephropathy: a bibliometric analysis and knowledge map visualization from 2012 to 2023. Int Urol Nephrol. https://doi.org/10.1007/s11255-023-03598-x

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wu H, Tong L, Wang Y, Yan H, Sun Z (2021) Bibliometric analysis of global research trends on ultrasound microbubble: a quickly developing field. Front Pharmacol 12:646626. https://doi.org/10.3389/fphar.2021.646626

    Article  PubMed  PubMed Central  Google Scholar 

  24. Shafiee MA, Hosseini SF, Mortazavi M et al (2021) Anticoagulation therapy in COVID-19 patients with chronic kidney disease. J Res Med Sci 26:63. https://doi.org/10.4103/jrms.JRMS_875_20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844–847. https://doi.org/10.1111/jth.14768

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Thachil J, Tang N, Gando S et al (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18(5):1023–1026. https://doi.org/10.1111/jth.14810

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Becker RC (2020) COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 50(1):54–67. https://doi.org/10.1007/s11239-020-02134-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Li J, Li SX, Zhao LF, Kong DL, Guo ZY (2020) Management recommendations for patients with chronic kidney disease during the novel coronavirus disease 2019 (COVID-19) epidemic. Chronic Dis Transl Med 6(2):119–123. https://doi.org/10.1016/j.cdtm.2020.05.001

    Article  PubMed  PubMed Central  Google Scholar 

  29. Diamantidis CJ, Cook DJ, Dunning S et al (2022) Missing care: the initial impact of the COVID-19 pandemic on CKD care delivery. J Gen Intern Med 37(16):4241–4247. https://doi.org/10.1007/s11606-022-07805-w

    Article  PubMed  PubMed Central  Google Scholar 

  30. Jiang JJ, Jenkins ZM, Crocker KM, Castle DJ (2023) Impact of the COVID-19 pandemic on access to healthcare, physical and mental health among patients with chronic kidney disease in Victoria. Australia Int Urol Nephrol 55(6):1635–1640. https://doi.org/10.1007/s11255-023-03480-w

    Article  PubMed  Google Scholar 

  31. El Shamy O, Tran H, Sharma S, Ronco C, Narayanan M, Uribarri J (2020) Telenephrology with remote peritoneal dialysis monitoring during coronavirus disease 19. Am J Nephrol 51(6):480–482. https://doi.org/10.1159/000508023

    Article  CAS  PubMed  Google Scholar 

  32. Gordon EJ, Fink JC, Fischer MJ (2013) Telenephrology: a novel approach to improve coordinated and collaborative care for chronic kidney disease. Nephrol Dial Transplant 28(4):972–981. https://doi.org/10.1093/ndt/gfs552

    Article  CAS  PubMed  Google Scholar 

  33. Stauss M, Floyd L, Becker S, Ponnusamy A, Woywodt A (2020) Opportunities in the cloud or pie in the sky? current status and future perspectives of telemedicine in nephrology. Clin Kidney J 14(2):492–506. https://doi.org/10.1093/ckj/sfaa103

    Article  PubMed  PubMed Central  Google Scholar 

  34. van Gelder VA, Scherpbier-de Haan ND, van Berkel S et al (2017) Web-based consultation between general practitioners and nephrologists: a cluster randomized controlled trial. Fam Pract 34(4):430–436. https://doi.org/10.1093/fampra/cmw131

    Article  PubMed  Google Scholar 

  35. Androga LA, Zoghby Z, Ramar P et al (2022) Provider perspectives and clinical outcomes with inpatient telenephrology. Clin J Am Soc Nephrol 17(5):655–662. https://doi.org/10.2215/CJN.13441021

    Article  PubMed  PubMed Central  Google Scholar 

  36. Hao W, Tang Q, Huang X, Ao L, Wang J, Xie D (2021) Analysis of the prevalence and influencing factors of depression and anxiety among maintenance dialysis patients during the COVID-19 pandemic. Int Urol Nephrol 53(7):1453–1461. https://doi.org/10.1007/s11255-021-02791-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hossain MM, Tasnim S, Sultana A et al (2020) Epidemiology of mental health problems in COVID-19: a review. Res 9:636. https://doi.org/10.12688/f1000research.24457.1

    Article  CAS  Google Scholar 

  38. Lee KM, Kim JS, Hwang S et al (2022) The higher the CKD stage, the higher the psychological stress in patients with CKD during COVID-19 pandemic. J Clin Med 11(16):4776. https://doi.org/10.3390/jcm11164776

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wang C, Pan R, Wan X et al (2020) Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 17(5):1729. https://doi.org/10.3390/ijerph17051729

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Huang Y, Zhao N (2020) Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res 288:112954. https://doi.org/10.1016/j.psychres.2020.112954

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Hao F, Tan W, Jiang L et al (2020) Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? a case-control study with service and research implications for immunopsychiatry. Brain Behav Immun 87:100–106. https://doi.org/10.1016/j.bbi.2020.04.069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bowling CB, Berkowitz TSZ, Smith B et al (2022) Unintended consequences of Covid-19 social distancing among older adults with kidney disease. J Gerontol A Biol Sci Med Sci 77(4):e133–e137. https://doi.org/10.1093/gerona/glab211

    Article  CAS  PubMed  Google Scholar 

  43. Yu JY, Kim JS, Hong CM et al (2021) Psychological distress of patients with end-stage kidney disease undergoing dialysis during the 2019 coronavirus disease pandemic: a cross-sectional study in a university Hospital. PLoS ONE 16(12):e0260929. https://doi.org/10.1371/journal.pone.0260929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Xiong HY, Zhang G, Wang L et al (2022) Psychological research of the children with chronic kidney disease and their guardians during the COVID-19 pandemic. Front Public Health 10:922678. https://doi.org/10.3389/fpubh.2022.922678

    Article  PubMed  PubMed Central  Google Scholar 

  45. Beaglehole B, Mulder RT, Frampton CM, Boden JM, Newton-Howes G, Bell CJ (2018) Psychological distress and psychiatric disorder after natural disasters: systematic review and meta-analysis. Br J Psychiatry 213(6):716–722. https://doi.org/10.1192/bjp.2018.210

    Article  PubMed  Google Scholar 

  46. Chaves C, Castellanos T, Abrams M, Vazquez C (2018) The impact of economic recessions on depression and individual and social well-being: the case of Spain (2006–2013). Soc Psychiatry Psychiatr Epidemiol 53(9):977–986. https://doi.org/10.1007/s00127-018-1558-2

    Article  CAS  PubMed  Google Scholar 

  47. Tapia Granados JA, Christine PJ, Ionides EL et al (2018) Cardiovascular risk factors, depression, and alcohol consumption during joblessness and during recessions among young adults in CARDIA. Am J Epidemiol 187(11):2339–2345. https://doi.org/10.1093/aje/kwy127

    Article  PubMed  PubMed Central  Google Scholar 

  48. Trakarnvanich T, Ngamvichchukorn T, Phumisantiphong U, Pholtawornkulchai K, Phochanasomboon K, Manomaipiboon A (2022) Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant. Vaccine 40(45):6499–6511. https://doi.org/10.1016/j.vaccine.2022.09.067

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Turner JS, O’Halloran JA, Kalaidina E et al (2021) SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596(7870):109–113. https://doi.org/10.1038/s41586-021-03738-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Danthu C, Hantz S, Dahlem A et al (2021) Humoral response after SARS-CoV-2 mRNA vaccination in a cohort of hemodialysis patients and kidney transplant recipients. J Am Soc Nephrol 32(9):2153–2158. https://doi.org/10.1681/ASN.2021040490

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Quiroga B, Soler MJ, Ortiz A et al (2022) Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study. Nephrol Dial Transplant 37(10):1868–1878. https://doi.org/10.1093/ndt/gfab313

    Article  CAS  PubMed  Google Scholar 

  52. Yoshifuji A, Toda M, Ryuzaki M et al (2022) Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis. Ren Replace Ther 8(1):39. https://doi.org/10.1186/s41100-022-00427-2

    Article  PubMed  PubMed Central  Google Scholar 

  53. Oyaert M, De Scheerder MA, Van Herrewege S et al (2022) Evaluation of humoral and cellular responses in SARS-CoV-2 mRNA vaccinated Immunocompromised patients. Front Immunol 13:858399. https://doi.org/10.3389/fimmu.2022.858399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study did not receive any funding.

Author information

Authors and Affiliations

  1. Renal DivisionKey Laboratory of Renal DiseaseKey Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Peking University First Hospital, Peking University Institute of Nephrology, Ministry of Health of China, Beijing, 100034, China

    Jingyu Wang & Xingzi Liu

  2. Vascular Surgery Department, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China

    Dikang Pan

  3. Department of Graduate School, Xinjiang Medical University, Urumqi, 830054, Xinjiang Province, China

    Xintian Cai

  4. Department of Cardiology, Peking University Third Hospital, Beijing, 100191, China

    Yuzhou Xue

  5. School of Nursing, Peking University, Beijing, 100191, China

    Jing Huang

Authors
  1. Jingyu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xingzi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dikang Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xintian Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuzhou Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

WJ Conceptualization, methodology, visualization, original draft preparation, and revision. LX: Conceptualization, original draft preparation. PD: Visualization. CX: Investigation. XY: Visualization. HJ: Conceptualization. All authors contributed to the article and approved the submitted version.

Corresponding author

Correspondence to Jingyu Wang.

Ethics declarations

Conflict of interest

The study was conducted without any business or financial relationships that could be interpreted as potential conflicts of interest.

Ethical approval

Not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 11 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Liu, X., Pan, D. et al. Chronic kidney disease in the shadow of COVID-19: insights from the bibliometric analysis. Int Urol Nephrol 56, 683–697 (2024). https://doi.org/10.1007/s11255-023-03706-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-023-03706-x

Keywords

Search

Navigation